baber/WOPTO huggingface dataset:
Patent NZ-578437-A (NZ)
Title: A method for determining the location of a rover unit with repsect to a boundary in an animal containment system using the polarity of a signal transmitted by a boundary wire of the animal containment system
Inventor: MOORE WILLIAM P
IPC: A01K15/02
Filed: 2008-01-17
Abstract: A method for determining the location of a rover unit with respect to a boundary in an animal training system is disclosed. The method comprises the steps of: (a) defining the boundary using a wire to define an area within the boundary and an area beyond the boundary where one of the area within the boundary and the area beyond the boundary is designated as a permitted area and the other designated as a restricted area; (b) providing a rover unit to be worn by the animal; (c) generating an activation signal; (d) modulating the activation signal; (e) dictating polarity of the first carrier cycle of the plurality of carrier cycles for each data bit of the plurality of data bits; (f) emphasizing the first carrier cycle of the activation signal; (g) transmitting the activation signal by way of the wire such that the activation signal generates a magnetic field about the wire where the activation signal has a polarity within the boundary that is substantially opposite its polarity beyond the boundary; (h) storing at the rover unit information indicative of the polarity of the activation signal within the boundary and the polarity of the activation signal beyond the boundary; (i) receiving the activation signal at the location of the rover unit; (j) analyzing the polarity of the activation signal with respect to the dictated polarity to determine whether the polarity corresponds to the polarity of the activation signal within the boundary or the polarity of the activation signal beyond the boundary; (k) not delivering a stimulus to the animal while the modulation of the activation signal with respect to the information indicative of the polarity of the activation signal indicates the rover unit is in the permitted area; (l) delivering a stimulus to the animal when the modulation of the activation signal with respect to the information indicative of the polarity of the activation signal indicates the rover unit moved from the permitted area to the restricted area; and (m) not delivering a stimulus to the animal when the modulation of the activation signal with respect to the information indicative of the polarity of the activation signal indicates the rover unit moved from the restricted area to the permitted area.
Patent NZ-588152-A (NZ)
Title: Pesticidal aqueous suspension composition
Inventor: ISHIHARA YOSHIAKI
IPC: A01N25/04
Filed: 2009-03-31
Abstract: Disclosed is a pesticidal composition with reduced viscosity and foaming properties, comprising: a.) An active ingredient compound of a sparingly water-soluble pesticide; b.) An organosilicone surface active agent (e.g. cyazofamid); c.) A viscosity-reducing agent (e.g. polyoxyethylene styrylphenyl); d.) An antifoaming agent; e.) A pH adjustor; and f.) A dispersant; Wherein b.) the organosilicone surface active agent is a polyalkylene-modified polymethylsiloxane non-ionic surface active agent, and d.) the antifoaming agent contains polydimethylsiloxane as an active ingredient. Further disclosed is a method for reducing the viscosity of a pesticidal aqueous suspension compositon and a method for reducing the foaming property of a pesticidal aqueous suspension composition, both comprising said composition.
Patent NZ-592143-A (NZ)
Title: Method for producing liquid and gaseous nitrogen streams, a helium-rich gaseous stream, and a denitrogened hydrocarbon stream
Inventor: PARADOWSKI HENRI
IPC: F25J1/02
Filed: 2009-10-02
Abstract: Disclosed is a process for producing a liquid nitrogen stream (18), a gaseous nitrogen stream (16), a gaseous stream (20) which is rich in helium and a denitrided stream (14) of hydrocarbons from a feed stream which contains hydrocarbons, nitrogen and helium, the process comprising the following steps: - expanding the feed stream (12) in order to form an expanded feed stream (70); - dividing the expanded feed stream (70) into a first introduction stream (72) and a second introduction stream (74); - cooling the first introduction stream (72) within an upstream heat exchanger (28) by heat exchange with a gaseous refrigerant stream (130) which is obtained by dynamic expansion in a cooling cycle (30) in order to obtain a first cooled introduction stream (76);- cooling the second introduction stream (74) by means of a first downstream heat exchanger (52) in order to form a second cooled introduction stream (80); - introducing the first cooled introduction stream (76) and the second cooled introduction stream (80) into a fractionating column (50) which comprises a plurality of theoretical fractionating stages; - tapping at least one reboiling stream (84) and circulating the reboiling stream (84) in the first downstream heat exchanger (52) in order to cool the second introduction stream (74); - tapping, at the bottom of the fractionating column (50), a bottom stream (86) which is intended to form the denitrided stream (14) of hydrocarbons; - tapping, at the head of the fractionating column (50), a head stream (90) which is rich in nitrogen; - reheating the head stream (90) which is rich in nitrogen by means of at least one second downstream heat exchanger (54, 56) in order to form a reheated stream (92) which is rich in nitrogen; - tapping and expanding a first portion (94) of the reheated stream (92) which is rich in nitrogen in order to form the gaseous nitrogen stream (16);- compressing a second portion (96) of the reheated stream (92) which is rich in nitrogen in order to form a compressed, recycled nitrogen stream (100), and cooling the compressed, recycled nitrogen stream (100) by means of circulation through the first downstream heat exchanger (52) and the or each second downstream heat exchanger (54,56);- liquefying and partially expanding the recycled nitrogen stream (100) in order to form an expanded nitrogen rich stream (106); - introducing at least a portion (106; 146) obtained from the expanded nitrogen rich stream (106) into a first separation container (60);- recovering the gaseous head stream from the first separation container (60) in order to form the helium rich stream (20);- recovering the liquid stream (110) from the bottom of the first separation container (60) and separating that liquid stream (110) into a liquid nitrogen stream (18) and a first reflux stream (114); - introducing the first reflux stream (114) as reflux into the head of the fractionating column (50).
Patent NZ-595757-A (NZ)
Title: Particulate porous aerosol generating material for a smoking article, wherein the aerosol generating material is impregnated with a diluent
Inventor: PLAKIDIS ANASTASIA
IPC: A24B15/28
Filed: 2010-04-28
Abstract: 595757 An aerosol generating material for a smoking article is disclosed. The aerosol generating material comprises particulate porous material (1) impregnated with a diluent (3), wherein the particulate porous material has a BET specific surface area of at least 1200 m2/g. The particulate porous material may be activated carbon, a resin or a metal organic framework. The diluent may be a polyol such as sorbitol, glycerol, or glycol, a non-polyol such as monohydric alcohol, high boiling point hydrocarbons, acids such as lactic acid, or esters such as diacetin, triacetin, triethyl citrate or isopropyl myristate. The particulate material, once impregnated and/ or loaded may be encapsulated in a barrier material such as a polysaccharide, e.g. alginate, dextran, maltodextrin, cyclodextrin and pectin, cellulosic materials, gelatin, gum or gel.
Patent NZ-596325-A (NZ)
Title: Biomarker for selecting patients and related methods
Inventor: ACRES BRUCE
IPC: G01N33/50
Filed: 2010-07-06
Abstract: 596325 Discloses an ex-vivo method for testing whether a patient will respond therapeutically to a method of treatment comprising administration of an immunogenic composition, wherein the testing method involves measuring levels of IL-10 and IFNy in a sample, calculating IL-10/IFNy ration and comparing said ration with a threshold level.
Patent NZ-600108-A (NZ)
Title: Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
Inventor: LASSALLE GILBERT
IPC: A61K31/4375
Filed: 2010-11-22
Abstract: 600108 Disclosed herein is a compound of formula (I), wherein the variables are defined herein, and the use thereof in the treatment of diseases linked to the activity of protein kinases, specifically by inhibiting the tyrosine kinase activity of PDGF-R, in particular PDGF-R beta, in Baf3 tel/PDGF cells and/or inhibiting the tyrosine kinase activity of Flt-3 in MV4-11 cells. Diseases to be treated include proliferative diseases such as cancers. Specific embodiments of the compound include the following: 2-{ 4-[7-amino-8-ethyl-6-(1H-imidazol-2-yl)-5-oxo-5,8-dihydro-[1,8]naphthyridin-2-yl]-2-fluoro-phenyl} -N-(1-ethyl-pyrrolidin-2-ylmethyl)-acetamide; 2-{ 4-[7-amino-8-cyclopropylmethyl-6-(1H-imidazol-2-yl)-5-oxo-5,8-dihydro-[1,8]naphthyridin-2-yl]-phenyl} -N-pyridin-4-ylmethyl-acetamide salt 5 of TFA; and 2-{ 4-[7-amino-8-ethyl-6-(1H-imidazol-2-yl)-5-oxo-5,8-dihydro-[1,8]naphthyridin-2-yl]-phenyl} -N-(4-cyclopropyl-morpholin-3-ylmethyl)-acetamide.
Patent NZ-600243-A (NZ)
Title: Combination of theobromine with a decongestant and its use for the treatment of cough
Inventor: BREW JOHN
IPC: A61K31/137
Filed: 2010-12-14
Abstract: ABSTRACT - 600243 The disclosure relates to an agent consisting of theobromine and a decongestant as a combined preparation for use in a therapy of cough, wherein the agent is manufactured for administration by an oral route, wherein the decongestant is selected from ephedrine, levmetamfetamine, naphazoline, oxymetazoline, phenylephrine, phenylpropanolamine, propylhexedrine, pseudoephedrine, synephrine and tetrahydrozoline, and wherein the decongestant, preferably pseudoephedrine, is to be administered in a dose of 0.1 to 30 mg/kg/day.
Patent NZ-612297-A (NZ)
Title: Glucagon analogs exhibiting gip receptor activity
Inventor: WARD BRIAN
IPC: C07K14/605
Filed: 2011-12-20
Abstract: Disclosed are glucagon agonist peptides of the sequences as defined in the specification and their use in reducing weight gain and for the treatment of diabetes.
Patent NZ-613070-A (NZ)
Title: 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as mglur5 modulators
Inventor: JAESCHKE GEORG
IPC: C07D413/06
Filed: 2012-04-17
Abstract: Disclosed herein are 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamide compounds of the general formula (I) and process for preparation thereof, wherein the variables are as defined in the specification. Examples of the compounds include 5-Phenylethynyl-pyridine-2-carboxylic acid tert-butylamide, 5-(4-Fluoro-phenylethynyl)-pyrimidine-2-carboxylic acid tert-butylamide and 5-(5-Chloro-pyridin-3-ylethynyl)-pyrimidine-2-carboxylic acid tert-butyl-methyl-amide. The compounds are positive allosteric modulators (PAM) of the metabotropic glutamate receptor subtype 5 (mGluR5). They may be useful in the treatment or prevention of acute and/or chronic neurological disorders such as psychosis, epilepsy, schizophrenia, Alzheimer’s disease, cognitive disorders and memory deficits, and chronic and acute pain.
Patent NZ-613671-A (NZ)
Title: Improved methods for determining cell viability using molecular nucleic acid-based techniques
Inventor: O’HARA SHAWN MARK
IPC: G01N33/48
Filed: 2011-12-27
Abstract: NZ 613671 Disclosed is a method for selectively excluding, from molecular detection, DNA of dead cells from a mixture containing live and dead cells, which method comprises removing dead microbe cell DNA prior to obtaining a positive non contaminated result from a nucleic acid amplification assay thereby indicating that viable cells are present, measuring two or more time points of microbe-specific signal increases from the amplification assay as an indication of the presence of viable microbes, eliminating amplification assay inhibitors from the mixture by the addition of a chemical denaturant, and determining the ratio of live to dead microbes present in the mixture.
Patent NZ-619465-A (NZ)
Title: Fluorination of aromatic ring systems
Inventor: DIMAGNO STEPHEN
IPC: C07C271/64
Filed: 2012-06-29
Abstract: This disclosure relates to reagents and methods useful in the synthesis of aryl fluorides, for example, in the preparation of 18F labelled radiotracers. The reagents and methods provided herein may be used to access a broad range of compounds, including aromatic compounds, heteroaromatic compounds, amino acids, nucleotides, and synthetic compounds.
Patent NZ-621365-A (NZ)
Title: Method for manufacturing edible transparent materials that can be used as containers for food products, and uses thereof
Inventor: BOUAZIZ HASSOUNA
IPC: A23L27/30
Filed: 2012-08-28
Abstract: The disclosure relates to a method for producing a food material essentially consisting of isomalt, characterised in that it includes the steps of: extruding and melting the material by raising the temperature to 80ºC to 160ºC, preferably to 150ºC to 160ºC; tempering so as to obtain the material in the stable crystalline form thereof and to eliminate the bubbles in the material; and pouring or injecting into moulds. The resulting material can be used as a container.
Patent NZ-623023-A (NZ)
Title: Apparatus for measuring the position of a vehicle or a surface thereof
Inventor: NAGY OLIVER
IPC: G01S13/42
Filed: 2014-03-28
Abstract: An apparatus (1) for measuring the position of a vehicle (2) or a surface thereof on a roadway (3) is disclosed. The apparatus (1) uses a plurality of spatially distributed radar receivers (13) in order to evaluate the radar beams of a single radar transmitter (11) that have been reflected by a vehicle (2) to be measured. An abundance of position information concerning the vehicle on the roadway (3) can be derived from the known geometric arrangement between various radar transmitters (11) on the one hand and radar receivers (13) on the other hand, more specifically just by comparison or joint evaluation of the received signals (14) of the various radar receivers without the need for complicated Doppler, time-of-flight or phase interference measurements.
Patent NZ-623113-A (NZ)
Title: Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
Inventor: PEARSALL ROBERT SCOTT
IPC: C07K19/00
Filed: 2010-08-13
Abstract: Disclosed is an isolated nucleotide that encodes an ActRIIB variant that hybridises to the complement of the nucleotide having the sequence as defined in the specification.
Patent NZ-624231-A (NZ)
Title: Assays and methods for selecting a treatment regimen for a subject with depression
Inventor: FAVA MAURIZIO
IPC: G01N33/68
Filed: 2012-11-14
Abstract: An assay for selecting a treatment regimen for a human subject with depression, comprising (a) subjecting a test sample previously obtained from a human subject, who is diagnosed as having depression or having a risk for depression, to at least one genotyping assay adapted to determine the genotypes of at least two loci. The at least two loci are: i. position 677 of SEQ ID NO. 1 or position 27 of SEQ ID NO. 7 (identified by rs1801133), where the SEQ ID NO. 1 and SEQ ID NO. 7 are each independently a portion of a genomic nucleic acid sequence of methylenetetrahydrofolate reductase (MTHFR) or ii.position 2756 of SEQ ID NO. 2 or position 27 of SEQ ID NO. 9 (identified by rs1805087), where the SEQ ID NO. 2 and SEQ ID NO. 9 are each independently a portion of a genomic nucleic acid sequence of methionine synthase (MTR). The assay furhter includes b) detecting from the genotypes of said at least two loci the presence of a single nucleotide polymorphism (SNP) selected from the following: i. a SNP677 at position 677 of SEQ ID NO. 1 or position 27 of SEQ ID NO. 7 comprising at least one thymine “T” allele; ii. a SNP2756 at position 2756 of SEQ ID NO.2 or position 27 of SEQ ID NO. 9 comprising at least one guanine “G” allele; and iii. a combination of at least one SNP677 T allele and at least one SNP2756 G allele; and if at least one of T allele at position SNP677 or at least one G allele at position SNP2756 or both at least one T allele at position SNP677 and at least one G allele at position SNP2756 is detected, then selecting a treatment regimen comprising an effective amount of a folate-containing compound.
Patent NZ-711672-A (NZ)
Title: Glass container composition
Inventor: BARTON STEPHEN D
IPC: C03C6/00
Filed: 2012-06-08
Abstract: A substantially clear glass container and related methods of manufacturing is disclosed. The glass container has a glass composition including soda-lime base glass materials, and an oxide of vanadium for good ultraviolet light blocking properties and an oxide of selenium to decolour the glass for good clarity and decolourization. The glass composition of the glass container also may include an oxide of sulphur.
Patent NZ-716350-A (NZ)
Title: Tricyclic benzoxaborole compounds and uses thereof
Inventor: ALLEY MICHAEL RICHARD KEVIN
IPC: C07F5/02
Filed: 2014-08-08
Abstract: Disclosed are Compounds of Formula II wherein X is selected from chloro or bromo, R1 and R2 are each independently selected from H or -CH3; compositions containing them, their use in therapy, including their use as anti-mycobacterial agents, for example in the treatment of a mycobacterial infection in a mammal, and methods for the preparation of such compounds, are provided. The compounds of this application are thereby provided as ring closed tricyclic analogues of (S)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol.
Patent NZ-719567-A (NZ)
Title: Box for packaging and exhibition, and packaging device for same
Inventor: NISHIKAWA YOICHI
IPC: B65D5/64
Filed: 2014-09-30
Abstract: In known boxes for packing and exhibiting a product, when the box is opened at a shop so as to exhibit products in the box, it is necessary to separate the separable portions of the rear surface walls and further to separate the separable portion of the rear surface wall, which takes time. Also, since the portions of the tray portion and the lid portion overlapping with each other are large, the amount of material necessary for forming the box increases, and thus manufacturing costs are high. The invention which overcomes these problems has a tray portion (21) constituted by a front receiving panel (1), a bottom surface panel (2), a rear surface panel (3), bottom side panels (6) integrally connected to the respective sides of the bottom surface panel (2), and rear side panels (7) integrally connected to the respective sides of the rear surface panel (3). A lid portion (22) is constituted by a top surface panel (4), a front surface panel (5), top side panels (8) integrally connected to the respective sides of the top surface panel (4), and front side panels (9) integrally connected to the respective sides of the front surface panel (5). The front receiving panel (1), the bottom surface panel (2), the rear surface panel (3), the top surface panel (4), and the front surface panel (5) are integrally connected one to another, and configured to cover products. A cut line (12a) for separating the lid portion (22) from the tray portion (21) is formed so as to pass through only an area of the rear surface panel (3), only an area of the top surface panel (4), or areas of both the rear surface panel (3) and the top surface panel (4). When products are exhibited in the tray portion (21), the lid portion (22) is severed along the cut line (12a), and separated from the tray portion (21).
Patent NZ-722033-A (NZ)
Title: Tankmix additive concentrates containing triglyceride fatty acid esters and methods of use
Inventor: TANK HOLGER
IPC: A01N65/00
Filed: 2013-03-14
Abstract: Tankmix additive concentrates containing a phosphate ester and/or polymeric surfactant and a triglyceride fatty acid ester and the use of aqueous herbicide spray mixtures incorporating such tankmix additive concentrates are described. The tankmix additive concentrates described herein include from 1 to 50 weight percent of a phosphate ester surfactant, a polymeric surfactant, or mixtures thereof, and from 1 to 90 weight percent of a triglyceride fatty acid ester. The tankmix additive concentrates form a stable emulsion upon dilution into a pesticide spray mixture.
Patent NZ-727003-A (NZ)
Title: An iloperidone metabolite for use in the treatment of psychiatric disorders
Inventor: FEENEY JOHN
IPC: A61K31/454
Filed: 2013-03-14
Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic. R-P88 is the R isomer of the iloperidone metabolite 1-(4-{ 3-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propoxy} -3-methoxy-phenyl)-ethanol. Examples of the psychiatric disorders that can be treated are: schizophrenia, schizoaffective disorder, bipolar disorder, (mania and/or depression), depression, major depression, psychotic episodes, autism, autism spectrum disorder, fragile X syndrome, and pervasive developmental disorder. R-P88 can be administered at lower doses or less frequently than the S isomer or iloperidone, and administration of R-P88 may result in a lower concentration of another iloperidone metabolite that is thought to cause orthostatic hypotension.
Patent NZ-727063-A (NZ)
Title: Compositions and methods of inhibiting masp-1, masp-2 and/or masp-3 for treatment of paroxysmal nocturnal hemoglobinuria
Inventor: DEMOPULOS GREGORY
IPC: A61K39/395
Filed: 2013-04-05
Abstract: Disclosed is a pharmaceutical composition comprising a MASP-2 inhibitory monoclonal antibody that specifically binds to human MASP-2 and a MASP-3 inhibitory monoclonal antibody that specifically binds to the serine protease domain of MASP-3 and inhibits factor D maturation. The composition inhibits both the lectin and alternative pathway of complement.
Patent NZ-728666-A (NZ)
Title: Transform map at printer cartridge
Inventor: NICHOLS STEPHEN J
IPC: B41J2/175
Filed: 2014-08-19
Abstract: To output data from an input device, such as a graphic, text or a combination thereof, output devices may convert the additive color model into a subtractive color model via a print color transform. Manufacturers and/or vendors are challenged to provide print color transform such that graphics and/or text are outputted from output devices, like a printer, with more accurate color representation. Disclosed are printer cartridges and memory devices for printer cartridges comprising a transform wrapper, the transform wrapper able to dynamically build a transform map for a printer from at least one of an existing map and primitive data based on metadata available to the memory device, the transform map able to facilitate the handling of multiple permutations of inks, color tables, print media and printers.
Patent NZ-732034-A (NZ)
Title: Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
Inventor: MAGNANI JOHN
IPC: C07H15/207
Filed: 2015-12-01
Abstract: Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood are disclosed. For example, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described and pharmaceutical compositions comprising at least one of the same.